Curaleaf Holdings, Inc.: Form 40-F/A for the period ended Dec 31, 2022
Filed with the SEC on May 3, 2023 and accepted by EDGAR at May 3, 2023, 17:29 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2022-01-01 to 2022-12-31 | $1.34bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2022-01-01 to 2022-12-31 | $757.3m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2022-01-01 to 2022-12-31 | $579.0m | us-gaap:GrossProfit |
| Selling, general and administrative | 12 months2022-01-01 to 2022-12-31 | $447.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2022-01-01 to 2022-12-31 | −$12.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2022-01-01 to 2022-12-31 | $150.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2022-01-01 to 2022-12-31 | −$370.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2022-01-01 to 2022-12-31 | −$0.52 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2022-01-01 to 2022-12-31 | −$0.52 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2022-01-01 to 2022-12-31 | 711,159,444 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2022-01-01 to 2022-12-31 | $46.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2022-01-01 to 2022-12-31 | $138.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2022-12-31 | $163.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-12-31 | $605.3m | us-gaap:AssetsCurrent |
| Total assets | At period end2022-12-31 | $3.40bn | us-gaap:Assets |
| Current liabilities | At period end2022-12-31 | $491.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-12-31 | $2.00bn | us-gaap:Liabilities |
| Long-term debt | At period end2022-12-31 | $570.9m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2022-12-31 | $52.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2022-12-31 | $1.28bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2022-12-31 | 623,520,125 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001558370-23-007893. Last ingested by Listed: Nov 5, 2026, 13:45 ET. Listed shows no prices and gives no investment advice.